2021
Skin Cancer Incidence in Organ Transplant Recipients Referred for Benign Skin Conditions
Chundydyal S, Cheng JY, Wang M, Li FY, Colegio OR. Skin Cancer Incidence in Organ Transplant Recipients Referred for Benign Skin Conditions. Dermatologic Surgery 2021, 47: 1428-1432. PMID: 34482329, DOI: 10.1097/dss.0000000000003181.Peer-Reviewed Original ResearchConceptsSolid organ transplant recipientsBenign skin conditionsOrgan transplant recipientsSkin conditionsTransplant recipientsCutaneous malignanciesAdult solid organ transplant recipientsDermatologic careAcademic tertiary care centerRetrospective case-control studySkin cancer outcomesTertiary care centerBetter risk stratificationBenign skin disordersCase-control studySkin cancer incidenceMalignant skin lesionsPrompt referralDermatology clinicRisk stratificationCancer outcomesCancer incidenceCare centerReferral reasonsSkin lesions
2018
Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients
Cheng JY, Li FY, Ko CJ, Colegio OR. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients. JAMA Dermatology 2018, 154: 60-66. PMID: 29167858, PMCID: PMC5833573, DOI: 10.1001/jamadermatol.2017.4506.Peer-Reviewed Original ResearchMeSH KeywordsAcademic Medical CentersAge DistributionAgedCarcinoma, Squamous CellCohort StudiesFemaleHumansImmunocompetenceIncidenceMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingOrgan TransplantationPrognosisRetrospective StudiesRisk AssessmentSex DistributionSkin NeoplasmsTransplant RecipientsUnited StatesConceptsSolid organ transplant recipientsSquamous cell carcinomaImmunocompetent control groupOrgan transplant recipientsImmunocompetent patientsTransplant recipientsImmunocompetent individualsMean ageCell carcinomaOutcome measuresControl groupStudy participantsCutaneous squamous cell carcinomaAggressive squamous cell carcinomaAnnual biopsy rateImmunosuppressive medication regimenRetrospective cohort studyDisease-specific deathSecondary outcome measuresPrimary outcome measureAggressive behaviorCumulative followOverall deathCohort studyImmunocompetent group